AB Science today announced that an abstract reporting results from its Phase 3 AB09004 study on Alzheimer’s disease has been selected for an oral presentation at the annual Alzheimer’s Association International Conference (AAIC)

NEXT STORY
Chembio Diagnostics Receives $4 Million HIV Test Purchase Order Supported by The Global Fund
PREV STORY
Dialysis Devices And Equipment Market Trends Allow For Flexible Treatment During COVID-19 Concerns
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Pfizer and BioNTech Announce Publication of Results from Landmark Phase 3 Trial of BNT162b2 COVID-19 Vaccine Candidate in The New England Journal of Medicine

author_avatar
NASDAQ Market News

Everest Medicines Announces First Patient Dosed in its Phase 2b Registration Clinical Trial of Trodelvy™ (sacituzumab govitecan) for Metastatic Triple-Negative Breast Cancer in China

author_avatar
NASDAQ Market News

Chimeric antigen receptor (CAR)-modified cytokine induced killer cell (CAR-CIK) technology featured at ASH

author_avatar
NASDAQ Market News